Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|November 10, 2018
Anti-angiogenic Therapy-Mediated Endothelial Damage: A Driver of Breast Cancer Recurrence?Laura Pisarsky, Cyrus M GhajarAngiogenesis|May 30, 2015
An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse modelsErnesta Fagiani, Ruben Bill, Laura Pisarsky, et al.Molecular Cancer Research : MCR|May 8, 2012
Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinomaAdrian Zumsteg, Christoph Caviezel, Laura Pisarsky, et al.Cell Reports|May 3, 2016
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic TherapyLaura Pisarsky, Ruben Bill, Ernesta Fagiani, et al.Molecular Oncology|May 31, 2021
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settingsRyann E Shor, Jinxiang Dai, Sun-Young Lee, et al.Therapeutic Advances in Medical Oncology|April 29, 2025
The antibody-drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical modelsDongli Liu, Cassandra J Vandenberg, Patrizia Sini, et al.Cancer Research|January 14, 2014
VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiationAnna Fantozzi, Dorothea C Gruber, Laura Pisarsky, et al.Biology of the Cell|June 17, 2018
Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinomaElmina Mammadova-Bach, Tristan Rupp, Caroline Spenlé, et al.Nature Cancer|February 5, 2022
Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brainJinxiang Dai, Patrick J Cimino, Kenneth H Gouin, et al.Mabs|December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancerPeter Jung, Stefan P Glaser, Jing Han, et al.Pageof 2